Hanna Wald
Jerusalem, JM 91121, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Entinostat Enhances Antigen-Specific CD8 T-Cell Response to Immunotherapies in Lung Cancer Models.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 31, 2026
Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1.
Journal: Frontiers in immunology
Published: September 26, 2024
Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.
Journal: Frontiers in immunology
Published: August 02, 2017
Matrix metalloproteinase 12 promotes tumor propagation in the lung.
Journal: The Journal of thoracic and cardiovascular surgery
Published: March 17, 2017
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.
Journal: Cancer research
Published: February 13, 2017
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 01, 2015
In the hunt for therapeutic targets: mimicking the growth, metastasis, and stromal associations of early-stage lung cancer using a novel orthotopic animal model.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 06, 2015
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype.
Journal: Oncotarget
Published: May 21, 2014
Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo.
Journal: Molecular cancer therapeutics
Published: February 08, 2014
Last Updated: 09/26/2026